Inhaled colistin for lower respiratory tract infections.
about
Precautionary practices of respiratory therapists and other health-care practitioners who administer aerosolized medicationsColistin for lung infection: an updateRasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance.Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.Inhaled antibiotics to treat lung infection.Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.Colistin: efficacy and safety in different populations.Challenges and opportunities in the treatment of ventilator-associated pneumonia.Clinical Pharmacokinetics and Pharmacodynamics of Colistin.Potential Toxicity of Polymyxins in Human Lung Epithelial Cells.Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children.The impact of team based interprofessional comprehensive assessments on the diagnosis and management of diabetic foot ulcers: A retrospective cohort study.Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections.Aerosolized antibiotics: the past, present and future, with a special emphasis on inhaled colistin.
P2860
Q23920021-4598B859-BA48-452C-9CB1-D5ADE97A4257Q28082041-1B815DAD-0DDF-4F73-A08D-BE37A43005E7Q34360893-A4830B09-567A-4316-B4B9-E48EDCA2FB6EQ36642374-50AB3335-4B20-4DAF-A78D-7BD7E03BE158Q37469403-2558B495-D731-40CF-94DE-01BF97F35DCAQ38162996-606311C6-2E3E-48D9-BBE2-9086C4BB8000Q38394222-AF6A5D71-0B19-4892-9C03-4998F046FE98Q38447194-A6B0FD6A-B793-4656-9F2D-C5F41F424913Q38514980-D1D22667-B4D7-4666-AAA9-3CF6344748D6Q38988630-463E7AC2-93FA-480B-960A-27839AC29E77Q39333751-84B37639-E2D8-44CD-AD95-263202EEA196Q40248118-42729A69-6F4A-460D-8EEB-2886809552F1Q41260939-277BD297-945B-49BE-9569-ECD77051CD33Q42364324-839A31C7-CD27-47EB-A4CE-86E8D921E924Q42930245-77DC396C-B2CD-4FFF-859C-3D47B43BD4BEQ45260700-CA67B53A-2B4C-437F-9412-C30766F3D4C1
P2860
Inhaled colistin for lower respiratory tract infections.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inhaled colistin for lower respiratory tract infections.
@en
Inhaled colistin for lower respiratory tract infections.
@nl
type
label
Inhaled colistin for lower respiratory tract infections.
@en
Inhaled colistin for lower respiratory tract infections.
@nl
prefLabel
Inhaled colistin for lower respiratory tract infections.
@en
Inhaled colistin for lower respiratory tract infections.
@nl
P2860
P1476
Inhaled colistin for lower respiratory tract infections
@en
P2093
Ileana Cojocaru
P2860
P304
P356
10.1517/17425247.2012.660480
P407
P577
2012-02-14T00:00:00Z